Driehaus Capital Management LLC Exagen Inc. Transaction History
Driehaus Capital Management LLC
- $9.17 Billion
- Q1 2025
A detailed history of Driehaus Capital Management LLC transactions in Exagen Inc. stock. As of the latest transaction made, Driehaus Capital Management LLC holds 418,505 shares of XGN stock, worth $2.93 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
418,505
Previous 418,505
-0.0%
Holding current value
$2.93 Million
Previous $1.72 Million
12.42%
% of portfolio
0.02%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding XGN
# of Institutions
40Shares Held
6.17MCall Options Held
3.4KPut Options Held
18.4K-
Rtw Investments, LP New York, NY1.51MShares$10.6 Million0.09% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6891KShares$6.23 Million0.01% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY532KShares$3.72 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA491KShares$3.43 Million0.0% of portfolio
-
Morgan Stanley New York, NY486KShares$3.4 Million0.0% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $114M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...